These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8758210)

  • 1. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.
    McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG
    J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T; Nomura N; Mori H; Wake N
    Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 expression, mutation, and allelic deletion in ovarian cancer.
    McManus DT; Yap EP; Maxwell P; Russell SE; Toner PG; McGee JO
    J Pathol; 1994 Nov; 174(3):159-68. PubMed ID: 7823248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
    Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC
    Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
    Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer.
    Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M
    Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
    Okamoto A; Sameshima Y; Yokoyama S; Terashima Y; Sugimura T; Terada M; Yokota J
    Cancer Res; 1991 Oct; 51(19):5171-6. PubMed ID: 1680546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [p53 alterations and chromosome 17 aberrations in non-small cell lung cancer].
    Tsuji T; Tagawa Y; Hisamatsu T; Nakamura S; Terada R; Sawai T; Yasutake T; Ayabe H
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():263-8. PubMed ID: 9263513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A; Sameshima Y; Yamada Y; Teshima S; Terashima Y; Terada M; Yokota J
    Cancer Res; 1991 Oct; 51(20):5632-5. PubMed ID: 1913680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity and overexpression of the p53 gene in ovarian carcinoma.
    Frank TS; Bartos RE; Haefner HK; Roberts JA; Wilson MD; Hubbell GP
    Mod Pathol; 1994 Jan; 7(1):3-8. PubMed ID: 7909153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
    Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between DNA content and p53 deletion in colorectal cancer.
    Cianchi F; Balzi M; Becciolini A; Giachè V; Messerini L; Palomba A; Tisti E; Faraoni P; Chellini F; Pucciani F; Perigli G; Cortesini C
    Eur J Surg; 1999 Apr; 165(4):363-8. PubMed ID: 10365839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
    Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT
    J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 and 17p allelic loss in colorectal carcinoma.
    Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN
    Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.
    Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU
    Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
    Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
    Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
    Thorlacius S; Börresen AL; Eyfjörd JE
    Cancer Res; 1993 Apr; 53(7):1637-41. PubMed ID: 8453635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.